Invest in these three high-yield stocks with an initial investment of $6,900 to earn an extra $500 per year in dividend income.
In the ever-evolving world of investments, finding stable and high-yield dividend stocks is a priority for many investors. Three such stocks that stand out are Altria Group, Healthpeak Properties, and Ares Capital.
Altria Group, a leading player in the tobacco industry, reported a decline in Q2 2025 revenues by 1.7%, but showed a robust 27.5% increase in operating income. This impressive growth was driven by strong pricing power, despite a 10.2% decline in domestic cigarette volumes. The company's adjusted EPS guidance was raised to a range of $5.35–$5.45, indicating confidence in premium pricing offsetting volume declines. Altria's Marlboro brand continues to dominate the premium cigarette market share at 59.5%, supporting above-inflation price increases. The stock currently offers an attractive yield of approximately 7.3%.
Healthpeak Properties, a healthcare-focused real estate investment trust (REIT), offers a dividend yield of around 6.9%. However, the company faced challenges due to reduced demand for biotech lab space post-pandemic, leading to a 2024 merger with Physicians Realty. This expansion into medical office buildings resulted in some dividend reduction due to share dilution, but adjusted funds from operations (FFO) rose to $0.44 per share in Q2, comfortably covering the quarterly dividend of $0.305 per share. Investors can expect future potential dividend increases as the integration stabilizes and demand for healthcare real estate remains essential.
Ares Capital, a large business development company (BDC), lends primarily to mid-sized businesses underserved by traditional banks. The company reported an average yield of 10.9% on its debt portfolio in Q3, reflecting strong income generation. Ares Capital has a 16-year history of steadily rising dividends and currently offers a high yield contributing to a diversified income stream. Its stock has been noted for steady payouts and solid total returns over time, making it appealing to high-yield dividend investors.
In summary, these three stocks are positioned as high-yield dividend investments with a focus on income stability and growth potential in their respective sectors. Altria relies on pricing power amid declining cigarette volume, Healthpeak on healthcare real estate resilience post-pandemic, and Ares Capital on lending to businesses seeking capital outside traditional banks.
| Company | Q2 2025 Highlights | Dividend Yield (approx.) | Outlook / Dividend Notes | |-----------------|------------------------------------------|-------------------------|--------------------------------------------------| | Altria Group | $6.1B revenue (-1.7%), operating income +27.5%, EPS guidance raised | 7.3% | Strong pricing offsets volume decline; stable high yield | | Healthpeak Props| FFO $0.44/share, dividend payment $0.305/qtr (some cut post-merger) | 6.9% | Merger impact; potential for future dividend growth | | Ares Capital | 10.9% avg yield on loan portfolio, steady dividend history | ~7.3% (part of average) | Strong income from loans; consistent rising payouts |
With these insights, adding shares of Ares Capital to a diversified portfolio now looks like a great way to build up your passive-income stream, offering an 8.4% yield. Meanwhile, Healthpeak and Altria Group, with their respective yields of 6.9% and 7.3%, present attractive opportunities for high-yield dividend investors seeking income stability and growth potential.
- In the realm of high-yield dividend stocks, Ares Capital, with an average yield of 10.9% on its debt portfolio, presents a great choice for diversifying one's passive-income stream, offering an approximately 8.4% yield.
- For investors who prioritize income stability and growth potential, Healthpeak Properties, offering a dividend yield of around 6.9%, can be an attractive choice, despite the post-merger dividend reduction.
- In the ever-evolving world of investments, Altria Group, despite a Q2 2025 revenue decline, remains a priority for many investors due to its robust operating income growth, strong pricing power, and an attractive yield of approximately 7.3%.
- When looking for businesses that lend to mid-sized companies underserved by traditional banks, Ares Capital, with a 16-year history of steadily rising dividends and a high yield contributing to a diversified income stream, emerges as an appealing option for high-yield dividend investors.
